Neurology Today in 5

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants
Apr 3, 2025 – 04:35
Impact of NIH cuts on neurology research, response to ACP’s guideline on migraine, an updated position on seizures, driver licensure, and medical reporting
Mar 20, 2025 – 05:06
Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists
Mar 6, 2025 – 04:44
IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function.
Feb 20, 2025 – 05:25
Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment
Feb 6, 2025 – 04:49
Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.
Jan 16, 2025 – 04:24
Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.
Jan 2, 2025 – 04:59
Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty
Dec 19, 2024 – 05:20
3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration
Dec 5, 2024 – 05:02
Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
Nov 21, 2024 – 04:40
Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression
Nov 7, 2024 – 04:20
Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
Oct 17, 2024 – 04:41
Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
Oct 3, 2024 – 04:32
Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s
Sep 19, 2024 – 04:46
Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism
Sep 5, 2024 – 05:04
Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
Aug 15, 2024 – 05:22
Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer
Jul 31, 2024 – 05:12
Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
Jul 18, 2024 – 05:17
Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology
Jul 4, 2024 – 05:10
When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
Jun 20, 2024 – 04:45
Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics
Jun 6, 2024 – 05:14
Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers
May 16, 2024 – 04:54
Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies
May 2, 2024 – 04:48
ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
Apr 18, 2024 – 04:31
BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
Apr 4, 2024 – 04:24
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
Mar 21, 2024 – 04:38
AI and 911 stroke detection, iatrogenic Alzheimer’s and human growth hormone, seizure dogs and refractory epilepsy
Mar 7, 2024 – 04:38
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
Feb 12, 2024 – 04:30
Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions
Jan 25, 2024 – 04:39
Rising incidence of Creutzfeldt-Jakob disease, therapy for prodromal migraine, neurotrauma of blast injury
Jan 16, 2024 – 04:18
DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023
Jan 2, 2024 – 04:08
Parkinson’s and suicide risk; biomarkers and underrepresentation in Alzheimer’s trials, immune system changes in ALS and Parkinson’s.
Dec 21, 2023 – 04:36
Serotonin and long COVID, Afib detected 3 years after stroke, Medicare on PET amyloid scans
Dec 7, 2023 – 04:43
A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
Nov 16, 2023 – 04:49
Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson’s disease
Nov 2, 2023 – 04:43
Blood pressure and endovascular therapy, cutbacks in neurology CME, blood test for Alzheimer’s
Oct 19, 2023 – 04:47
Football and Parkinson’s, deep brain stimulation for stroke recovery, neuroprostheses for anarthric patients
Oct 5, 2023 – 04:47
Medicare coverage of carotid stenting, disparities in vulnerable neuro-oncology patients, optical EMG for neuromuscular disorders.
Sep 21, 2023 – 05:12
Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab.
Sep 7, 2023 – 05:27
Oral health and cognitive decline; managing first-ever sleep seizures; growth of concierge neurology.
Aug 17, 2023 – 04:56
Gene variants and MS severity, AI and EEG reads, neuroprotective agent for ischemic stroke
Aug 3, 2023 – 05:43
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
Jul 20, 2023 – 05:12
Gout and risk of neurodegenereative diseases, Tenecteplase compared with warfarin, cognitive decline after heart attack
Jul 6, 2023 – 05:27
Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson’s, gene variant confers resilience against autosomal dominant Alzheimer’s.
Jun 15, 2023 – 05:29
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
Jun 1, 2023 – 05:12
Assay detects Parkinson’s before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE
May 18, 2023 – 05:23
Anticoagulants for patients with dementia and Afib, tau levels in women taking hormone replace therapy, neurohumanities programs for neurology residents.
May 4, 2023 – 05:56
Fertility treatments for women with MS, stroke systems of care, ravalizumab for NMOSD
Apr 20, 2023 – 05:59
Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
Apr 6, 2023 – 06:06
Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.
Mar 16, 2023 – 06:07